| Dr Arian Nachat, MD | |
|
301 E 13th St, Merced, CA 95340-6211 | |
| (209) 385-7111 | |
| (209) 385-7066 |
| Full Name | Dr Arian Nachat |
|---|---|
| Gender | Female |
| Speciality | Hospice/palliative Care |
| Experience | 23 Years |
| Location | 301 E 13th St, Merced, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407892391 | NPI | - | NPPES |
| 00A899910 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD182673 (Oregon) | Secondary |
| 207P00000X | Emergency Medicine | A89991 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scripps Health Inpatient Providers Medical Group Inc | 9436314762 | 143 |
News Archive
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. today announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) as a treatment for pediatric eosinophilic esophagitis (EoE). The study was designed to evaluate improvement in the co-primary endpoints of changes in esophageal eosinophil levels and clinical symptoms.
The University of Illinois at Chicago will soon test a vaccine for COVID-19.
According to a leader of Britain's midwives, more and more women are being discouraged from giving birth at home. Cathy Warwick, general secretary of the Royal College of Midwives said that many GPs are citing harms of a home birth like dangerous bleeding where their midwives may be unable to help. Warwick said, "There are doctors that still tell women scary things that aren't evidence-based that then put them off having a home birth…
In the week that the University of Leicester celebrates the 25th anniversary of the discovery of DNA fingerprinting (Thursday September 10) new findings from the world-renowned University of Leicester Department of Genetics reveal for the first time that the male and female do truly communicate -at least at the fundamental genetic level.
Cytori Therapeutics, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Jefferies & Company, Inc. is acting as sole book-running manager for the offering.
› Verified 8 days ago
| Entity Name | Amador Emergency Physicians Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417040619 PECOS PAC ID: 2567495716 Enrollment ID: O20050916000969 |
News Archive
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. today announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) as a treatment for pediatric eosinophilic esophagitis (EoE). The study was designed to evaluate improvement in the co-primary endpoints of changes in esophageal eosinophil levels and clinical symptoms.
The University of Illinois at Chicago will soon test a vaccine for COVID-19.
According to a leader of Britain's midwives, more and more women are being discouraged from giving birth at home. Cathy Warwick, general secretary of the Royal College of Midwives said that many GPs are citing harms of a home birth like dangerous bleeding where their midwives may be unable to help. Warwick said, "There are doctors that still tell women scary things that aren't evidence-based that then put them off having a home birth…
In the week that the University of Leicester celebrates the 25th anniversary of the discovery of DNA fingerprinting (Thursday September 10) new findings from the world-renowned University of Leicester Department of Genetics reveal for the first time that the male and female do truly communicate -at least at the fundamental genetic level.
Cytori Therapeutics, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Jefferies & Company, Inc. is acting as sole book-running manager for the offering.
› Verified 8 days ago
| Entity Name | Scripps Health Inpatient Providers Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699043000 PECOS PAC ID: 9436314762 Enrollment ID: O20120711000317 |
News Archive
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. today announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) as a treatment for pediatric eosinophilic esophagitis (EoE). The study was designed to evaluate improvement in the co-primary endpoints of changes in esophageal eosinophil levels and clinical symptoms.
The University of Illinois at Chicago will soon test a vaccine for COVID-19.
According to a leader of Britain's midwives, more and more women are being discouraged from giving birth at home. Cathy Warwick, general secretary of the Royal College of Midwives said that many GPs are citing harms of a home birth like dangerous bleeding where their midwives may be unable to help. Warwick said, "There are doctors that still tell women scary things that aren't evidence-based that then put them off having a home birth…
In the week that the University of Leicester celebrates the 25th anniversary of the discovery of DNA fingerprinting (Thursday September 10) new findings from the world-renowned University of Leicester Department of Genetics reveal for the first time that the male and female do truly communicate -at least at the fundamental genetic level.
Cytori Therapeutics, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Jefferies & Company, Inc. is acting as sole book-running manager for the offering.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arian Nachat, MD 323 Grand Ave, Long Beach, CA 90814-2739 Ph: (562) 434-1464 | Dr Arian Nachat, MD 301 E 13th St, Merced, CA 95340-6211 Ph: (209) 385-7111 |
News Archive
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. today announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) as a treatment for pediatric eosinophilic esophagitis (EoE). The study was designed to evaluate improvement in the co-primary endpoints of changes in esophageal eosinophil levels and clinical symptoms.
The University of Illinois at Chicago will soon test a vaccine for COVID-19.
According to a leader of Britain's midwives, more and more women are being discouraged from giving birth at home. Cathy Warwick, general secretary of the Royal College of Midwives said that many GPs are citing harms of a home birth like dangerous bleeding where their midwives may be unable to help. Warwick said, "There are doctors that still tell women scary things that aren't evidence-based that then put them off having a home birth…
In the week that the University of Leicester celebrates the 25th anniversary of the discovery of DNA fingerprinting (Thursday September 10) new findings from the world-renowned University of Leicester Department of Genetics reveal for the first time that the male and female do truly communicate -at least at the fundamental genetic level.
Cytori Therapeutics, Inc. today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Jefferies & Company, Inc. is acting as sole book-running manager for the offering.
› Verified 8 days ago
Dr. John William Mcneil Ii, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 333 Mercy Ave, Merced, CA 95340 Phone: 209-564-5000 | |
Ma Lovely Batasin, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 333 Mercy Ave, Merced, CA 95340 Phone: 209-564-5000 | |
Martin Rossip, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3278 Denver Ave, Ofc, Merced, CA 95348 Phone: 209-725-8000 | |
Gagan Deep Singh, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 836 Round Hill Dr, Merced, CA 95348 Phone: 718-501-4585 | |
Dr. Stephen John Backman, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 E 13th St, Merced, CA 95340 Phone: 209-385-7111 Fax: 209-385-7066 | |
James C. Hardy Jr., Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 E 13th St, Merced, CA 95340 Phone: 209-385-7111 Fax: 209-385-7066 | |
Dr. John Thomas Ludlow, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 333 Mercy Ave, Merced, CA 95340 Phone: 209-564-5000 |